Devouassoux et al. found no difference in CD4+ or CD8+ T‐cells in transbronchial biopsies taken during the first year post‐transplant between patients who would remain stable and those who would develop BOS. The gene discussed is CD8A; the disease is Buschke-Ollendorff syndrome.